Disseminated intravascular coagulation in carcinoma of prostate: role of estrogen therapy.

[1]  W. Swaim,et al.  Disseminated intravascular coagulation in the urologic patient. , 1976, The Journal of urology.

[2]  W. C. Adkins,et al.  Regression of prostatic cancer metastasis by high doses of diethylstilbestrol diphosphate. , 1976, Urology.

[3]  J. Schmidt,et al.  Paraplegia and paraparesis due to prostatic cancer. Use of intravenous diethylstilbestrol diphosphate. , 1974, Urology.

[4]  P. Band,et al.  High-dose diethylstilbestrol diphosphate therapy of prostatic cancer after failure of standard doses of estrogens. , 1973, Canadian Medical Association journal.

[5]  C. W. Reiquam,et al.  Disseminated intravascular coagulation in cancer patients: Supportive evidence , 1973, Cancer.

[6]  H. Marberger,et al.  Prostatic carcinoma: treatment of advanced cases with intravenous diethylstilbestrol diphosphate. , 1955, The Journal of urology.

[7]  W. Whitmore,et al.  Fibrinolysis in metastatic cancer of the prostate , 1952, Cancer.

[8]  P. J. Clark,et al.  QUANTITATIVE STUDIES OF PROSTATIC SECRETION , 1940, The Journal of experimental medicine.

[9]  C. Huggins,et al.  QUANTITATIVE STUDIES OF PROSTATIC SECRETION , 1939, The Journal of experimental medicine.

[10]  Straub Pw.  Chronic intravascular coagulation. Clinical spectrum and diagnostic criteria, with special emphasis on metabolism, distribution and localization of I 131 -fibrinogen. , 1971 .

[11]  J. Rasmussen,et al.  Fibrinolysis and thromboplastic activity in relation to hemorrhage in transvesical prostatectomy. , 1961, Scandinavian journal of clinical and laboratory investigation.